Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor: Merck Sharp & Dohme LLC
Summary
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Official title: An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1200
Start Date
2024-04-14
Completion Date
2031-04-12
Last Updated
2026-10-13
Healthy Volunteers
No
Conditions
Interventions
Sacituzumab tirumotecan
IV infusion
Pembrolizumab
IV infusion
Paclitaxel
IV infusion
Nab-paclitaxel
IV infusion
Capecitabine
oral tablet
Liposomal doxorubicin
IV infusion
Locations (259)
Ironwood Cancer & Research Centers ( Site 0066)
Chandler, Arizona, United States
Banner MD Anderson Cancer Center-Oncology ( Site 0004)
Gilbert, Arizona, United States
Providence Medical Foundation-Oncology ( Site 0020)
Fullerton, California, United States
Moores Cancer Center ( Site 0059)
La Jolla, California, United States
Cancer and Blood Specialty Clinic ( Site 0001)
Los Alamitos, California, United States
University of Colorado Anschutz Medical Campus ( Site 0061)
Aurora, Colorado, United States
UCHealth Cherry Creek Medical Center ( Site 0094)
Denver, Colorado, United States
University of Colorado Health - Highlands Ranch Hospital ( Site 0095)
Highlands Ranch, Colorado, United States
Yale Cancer Center ( Site 0060)
New Haven, Connecticut, United States
Stamford Hospital ( Site 0049)
Stamford, Connecticut, United States
AdventHealth Altamonte Springs ( Site 0021)
Altamonte Springs, Florida, United States
University of Florida College of Medicine ( Site 0063)
Gainesville, Florida, United States
Orlando Health Cancer Institute ( Site 0011)
Orlando, Florida, United States
Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0032)
Thomasville, Georgia, United States
Rush University Medical Center ( Site 0079)
Chicago, Illinois, United States
University of Chicago Medical Center ( Site 0067)
Chicago, Illinois, United States
Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053)
Edgewood, Kentucky, United States
Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042)
Baton Rouge, Louisiana, United States
Greenebaum Comprehensive Cancer Center ( Site 0036)
Baltimore, Maryland, United States
Mercy Medical Center - Baltimore-Medical Oncology and Hematology ( Site 0028)
Baltimore, Maryland, United States
Holy Cross Hospital ( Site 0073)
Silver Spring, Maryland, United States
Dana-Farber Cancer Institute-Breast Oncology Center ( Site 0037)
Boston, Massachusetts, United States
Henry Ford Health ( Site 0002)
Detroit, Michigan, United States
Saint Luke's Cancer Institute ( Site 0027)
Kansas City, Missouri, United States
Washington University School of Medicine ( Site 0076)
St Louis, Missouri, United States
NYU Langone Health - Brooklyn ( Site 0089)
Brooklyn, New York, United States
NYU Langone Hospital - Long Island ( Site 0090)
Mineola, New York, United States
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068)
New York, New York, United States
Hematology Oncology Associates of Rockland ( Site 0054)
Nyack, New York, United States
Stony Brook University-Cancer Center ( Site 0034)
Stony Brook, New York, United States
Levine Cancer Institute ( Site 0014)
Charlotte, North Carolina, United States
Zangmeister Cancer Center ( Site 7000)
Columbus, Ohio, United States
Providence Portland Medical Center ( Site 0044)
Portland, Oregon, United States
Providence St. Vincent Medical Center ( Site 0081)
Portland, Oregon, United States
Thomas Jefferson University - Clinical Research Institute ( Site 0056)
Philadelphia, Pennsylvania, United States
Texas Oncology-Dallas Presbyterian Hospital ( Site 8000)
Dallas, Texas, United States
Parkland Health and Hospital System ( Site 0069)
Dallas, Texas, United States
UT Southwestern Medical Center ( Site 0050)
Dallas, Texas, United States
The Center for Cancer and Blood Disorders ( Site 0041)
Fort Worth, Texas, United States
Texas Oncology - San Antonio ( Site 8002)
San Antonio, Texas, United States
The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0057)
Tyler, Texas, United States
Inova Schar Cancer Institute ( Site 0025)
Fairfax, Virginia, United States
Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015)
Midlothian, Virginia, United States
VCU Health Adult Outpatient Pavillion ( Site 0070)
Richmond, Virginia, United States
Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8001)
Roanoke, Virginia, United States
University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040)
Madison, Wisconsin, United States
Instituto Alexander Fleming-Alexander Fleming ( Site 0382)
Buenos Aires, Buenos Aires F.D., Argentina
Fundacion Estudios Clinicos-Oncology ( Site 0384)
Rosario, Santa Fe Province, Argentina
Hospital Aleman-Oncology ( Site 0386)
Buenos Aires, Argentina
Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0383)
Buenos Aires, Argentina
Hospital Italiano de Córdoba ( Site 0385)
Córdoba, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0387)
La Rioja, Argentina
Macquarie University-MQ Health Clinical Trials Unit ( Site 2002)
Macquarie University, New South Wales, Australia
Westmead Hospital ( Site 2000)
Westmead, New South Wales, Australia
Frankston Hospital-Oncology and Haematology ( Site 2003)
Frankston, Victoria, Australia
Fiona Stanley Hospital-Medical Oncology ( Site 2004)
Murdoch, Western Australia, Australia
Institut Jules Bordet-Medicine Oncology ( Site 1104)
Anderlecht, Bruxelles-Capitale, Region de, Belgium
Cliniques universitaires Saint-Luc-Medical Oncology ( Site 1103)
Brussels, Bruxelles-Capitale, Region de, Belgium
Jessa Ziekenhuis-Limburgs Oncologisch Centrum ( Site 1105)
Hasselt, Limburg, Belgium
AZ Maria Middelares-IKG ( Site 1106)
Ghent, Oost-Vlaanderen, Belgium
Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 1107)
Namur, Belgium
Oncoclínica Oncologistas Associados-Clinical Research ( Site 0407)
Teresina, Piauí, Brazil
Hospital Moinhos de Vento ( Site 0403)
Porto Alegre, Rio Grande do Sul, Brazil
Hospital do Câncer Mãe de Deus ( Site 0404)
Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Oncologia Saint Gallen ( Site 0412)
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Instituto do Câncer Brasil - Unidade Taubaté ( Site 0408)
Taubaté, São Paulo, Brazil
IBCC - Núcleo de Pesquisa e Ensino ( Site 0401)
São Paulo, Brazil
BC Cancer Surrey ( Site 0315)
Surrey, British Columbia, Canada
Southlake Health ( Site 0311)
Newmarket, Ontario, Canada
Princess Margaret Cancer Centre ( Site 0310)
Toronto, Ontario, Canada
CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0301)
Montreal, Quebec, Canada
Jewish General Hospital ( Site 0303)
Montreal, Quebec, Canada
CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0302)
Québec, Quebec, Canada
Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0308)
Rimouski, Quebec, Canada
FALP-UIDO ( Site 0451)
Santiago, Region M. de Santiago, Chile
Oncovida ( Site 0453)
Santiago, Region M. de Santiago, Chile
Clínica RedSalud Vitacura ( Site 0455)
Santiago, Region M. de Santiago, Chile
Pontificia Universidad Catolica de Chile ( Site 0454)
Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 0452)
Santiago, Region M. de Santiago, Chile
Bradford Hill Norte ( Site 0456)
Antofagasta, Chile
Fundacion Colombiana de Cancerología Clinica Vida ( Site 0506)
Medellín, Antioquia, Colombia
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0507)
Bogotá, Bogota D.C., Colombia
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0501)
Valledupar, Cesar Department, Colombia
IMAT S.A.S ( Site 0502)
Montería, Departamento de Córdoba, Colombia
Fundación Valle del Lili ( Site 0508)
Cali, Valle del Cauca Department, Colombia
CIMCA ( Site 0551)
San José, Provincia de San José, Costa Rica
Hospital Metropolitano - Sede Lindora ( Site 0550)
Santa Ana, Provincia de San José, Costa Rica
ICIMED ( Site 0552)
San José, Costa Rica
Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 1134)
Ostrava-Poruba, Moravian-Silesian Region, Czechia
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1132)
Olomouc, Olomouc Region, Czechia
Nemocnice Ceske Budejovice-Onkologicke oddeleni ( Site 1138)
České Budějovice, South Bohemian Region, Czechia
Fakultni nemocnice Kralovske Vinohrady-Onkologická klinika ( Site 1135)
Prague, Czechia
Fakultní nemocnice Motol a Homolka ( Site 1136)
Prague, Czechia
Rigshospitalet ( Site 1180)
Copenhagen, Capital Region, Denmark
Nordsjællands Hospital - Hillerød ( Site 1184)
Hillerød, Capital Region, Denmark
Næstved Sygehus ( Site 1182)
Næstved, Region Sjælland, Denmark
Odense Universitetshospital ( Site 1181)
Odense C, Region Syddanmark, Denmark
Vejle Sygehus ( Site 1183)
Vejle, Region Syddanmark, Denmark
Hopital Prive Jean Mermoz-Oncology ( Site 1246)
Lyon, Auvergne-Rhône-Alpes, France
Centre François Baclesse ( Site 1250)
Caen, Calvados, France